I-Mab to Participate in September Investor Conferences

Cantor Global Healthcare Conference Format: One-on-one meetings Date: September 3-5, 2025 ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab's management team will participate in the following upcoming investor conferences in September, 2025: H.C. Wainwright 27 Annual Global Investment Conference Conference details a ...